Calvert Crary provides independent investment research on corporate legal matters to hedge funds and institutional investors. Mr. Crary, an expert in patent litigation, has over 30 years of experience analyzing lawsuits for the financial community. His analytical reports called Litigation Notes cover a range of sectors with a focus on pharmaceuticals, major drugs, health care, biotechnology, high technology, and tobacco. Click here to view our coverage list.

On Wall Street, legal disputes cause significant volatility in the price of securities. The stocks of companies with such litigation are inefficiently priced and for this reason are ideal trading vehicles. Thus, the implications of a single verdict for investors can be profound. Our reports address the investment significance of corporate legal disputes in a clear and concise manner that is easily comprehensible to lawyers and non-lawyers alike. Crary provides an inside look at the legal system, drawing upon his extensive experience to predict how a case will be decided. His unique method provides our select group of clients the opportunity to profit from his analysis.

Sample reports -

• Cephalon’s Reverse Payment Settlement Litigation
• Potential Lawsuit by Johnson & Johnson to Terminate Centocor Agreement with Schering-Plough
• Sequenom DNA Sequencing Patent Litigation

© 2010 Calvert D. Crary, Litigation Notes: Independent Investment Research